Sophia (Sujin) Kim 11/26/24 Sophia (Sujin) Kim 11/26/24

Orum Therapeutics Selected for the 2024 Venture 100 Billion Won Companies Club by the Korean Ministry of SMEs and Startups

Sophia (Sujin) Kim 11/21/24 Sophia (Sujin) Kim 11/21/24

Notice of New Share Issuance for KOSDAQ Listing

SungJoo Lee 10/2/24 SungJoo Lee 10/2/24

Orum Therapeutics Submits Registration Statement for KOSDAQ Listing

Kyuri Kim 7/16/24 Kyuri Kim 7/16/24

Orum Therapeutics Announces a Global, Multi-Target License and Option Agreement with Vertex for the Use of Orum’s TPD²® Technology to Develop Novel Degrader-Antibody Conjugates

SungJoo Lee 11/6/23 SungJoo Lee 11/6/23

Orum Therapeutics Announces Acquisition of ORM-6151 Program by Bristol Myers Squibb